Plant Pathogen Initiative – Request for Partnership 2024 is now open
The Plant Pathogen Omics Initiative has opened its 2024 Request for Partnership.
Major breakthrough in type 1 diabetes: PromarkerD predicts kidney disease
Proteomics International Laboratories' Promarker D test effectively forecasts renal decline in patients with type 1 diabetes.
Parliamentary Friends of Science event highlights Australia’s synthetic biology future
At a recent Parliamentary Friends of Science event, synthetic biology took centre stage as a transformative force ready to reshape industries and tackle global challenges.
Advancing human genomics research through enhanced data sharing
The Bioplatforms-supported Australian BioCommons is leading key projects to improve access to human genomics data.
Drug Target Identification node establishment at the Monash Proteomics and Metabolomics Platform
The Bioplatforms-supported Monash Proteomics & Metabolomics Platform has launched Australia’s first Drug Target Identification node, thanks to a successful MRFF grant led by Prof. Darren Creek.
Pioneering Australian vaccine innovation in the wake of Covid-19
Sementis is revolutionising vaccine development by rapidly addressing infectious diseases such as COVID-19, Chikungunya, and Zika in collaboration with SAGC and the Experimental Therapeutics Laboratory.
Genomic research and Indigenous knowledge collaborate to protect the greater bilby
A new study has combined genomic research and Indigenous knowledge to enhance conservation efforts for the greater bilby, also known as the Ninu.
Celebrating conservation and innovation in the 2024 Eureka Prizes
Bioplatforms Australia is proud to announce the remarkable achievements of its affiliate researchers who have been named finalists in the 2024 Eureka Prizes.